Claire Pomeroy's most recent trade in Embecta Corp was a trade of 13,839 Common Stock done . Disclosure was reported to the exchange on Feb. 12, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Embecta Corp | Claire Pomeroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 13,839 | 41,289 | - | 0 | Common Stock | |
Haemonetics Corp. | Claire Pomeroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,207 | 14,179 (0%) | 0% | - | Common Stock | |
Embecta Corp | Claire Pomeroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 11,455 | 26,443 | - | 0 | Common Stock | |
Haemonetics Corp. | Claire Pomeroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 2,226 | 11,972 (0%) | 0% | - | Common Stock | |
Embecta Corp | Claire Pomeroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 6,979 | 14,631 | - | 0 | Common Stock | |
Haemonetics Corp. | Claire Pomeroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 2,730 | 9,746 (0%) | 0% | - | Common Stock | |
Embecta Corp | Claire Pomeroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 6,024 | 8,021 | - | 0 | Common Stock | |
Becton, Dickinson & Company | Claire Pomeroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 9,982 (0%) | 0% | 0 | Common Stock | |
Haemonetics Corp. | Claire Pomeroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 3,077 | 7,016 (0%) | 0% | - | Common Stock | |
Becton, Dickinson & Company | Claire Pomeroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 8,956 (0%) | 0% | 0 | Common Stock | |
Haemonetics Corp. | Claire Pomeroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2020 | 1,983 | 3,939 (0%) | 0% | - | Common Stock |